Journal of Pharmacology and Experimental Therapeutics
ISSN 0022-3565 · American Society for Pharmacology and Experimental Therapeutics · United States · active 1909–2026
Metrics
- Scimago quartile
- Q2
- Cites per paper (2y)
- 0.8
- SJR
- 0.921
- h-index
- 325
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 30 September 2026 (venue index build).
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
- Indexed in
- ScopusWeb of SciencePubMed
- Access status:
- unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Journal of Pharmacology and Experimental Therapeutics a predatory journal?
Our screening does not flag Journal of Pharmacology and Experimental Therapeutics. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Journal of Pharmacology and Experimental Therapeutics indexed in Scopus or Web of Science?
Per our venue index, Journal of Pharmacology and Experimental Therapeutics appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Journal of Pharmacology and Experimental Therapeutics?
Papers in Journal of Pharmacology and Experimental Therapeutics are cited about 0.8 times each within two years of publication, and Scimago places it in Q2, with an h-index of 325. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Journal of Pharmacology and Experimental Therapeutics (Q1, Q2, Q3, or Q4)?
Scimago places Journal of Pharmacology and Experimental Therapeutics in Q2 for its subject category. Quartiles split the journals in a field into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Journal of Pharmacology and Experimental Therapeutics is cited about 0.8 times per paper over two years, with an h-index of 325. A journal is ranked per subject category, so one spanning several fields can sit in different quartiles depending on the category.
What is the Web of Science (JCR) quartile of Journal of Pharmacology and Experimental Therapeutics?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Journal of Pharmacology and Experimental Therapeutics. The open equivalent is its Scimago quartile, Q2, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Journal of Pharmacology and Experimental Therapeutics open access?
We hold no reliable open-access classification for Journal of Pharmacology and Experimental Therapeutics. Check the journal's own site for its access model and any article processing charge.
Ready to submit? Tools for your next paper
Similar venues
- Pharmacological ReviewsQ1 · American Society for Pharmacology and Experimental Therapeutics
- Journal of Psychiatry and NeuroscienceQ1 · Canadian Medical Association
- Nature reviews. NeuroscienceQ1 · Nature Portfolio
- Progress in Lipid ResearchQ1 · Elsevier BV
- Pharmacology & TherapeuticsQ1 · Elsevier BV
- Pharmacological ResearchQ1 · Elsevier BV
Compare it with its peers: Ranked Cellular and Molecular Neuroscience journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.